Toripalimab in Combination With Induction Chemotherapy and Subsequent Chemoradiation as First-Line Treatment in Patients With Advanced/Metastatic Esophageal Carcinoma: Protocol for a Single-Arm, Prospective, Open-Label, Phase II Clinical Trial (TR-EAT)

Immune checkpoint inhibitor therapy combined with chemotherapy is safe and effective in treating advanced esophageal carcinoma; however, some patients still experience tumor progression and/or metastasis. Whether the addition of radiotherapy to immunotherapy combined with chemotherapy improves the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Lei, Wang, Yi, Li, Baisen, Wan, Gang, Liang, Long, Li, Tao, Lang, Jinyi, Wang, Qifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024160/
https://www.ncbi.nlm.nih.gov/pubmed/35463350
http://dx.doi.org/10.3389/fonc.2022.878851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024160/
https://www.ncbi.nlm.nih.gov/pubmed/35463350
http://dx.doi.org/10.3389/fonc.2022.878851

Ejemplares similares